Purnanand D. Sarma

2021

In 2021, Purnanand D. Sarma earned a total compensation of $2.1M as President, Chief Executive Officer and Director at Immunome, a 25% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$189,000
Option Awards$1,371,370
Salary$540,000
Other$11,914
Total$2,112,284

Sarma received $1.4M in option awards, accounting for 65% of the total pay in 2021.

Sarma also received $189K in non-equity incentive plan, $540K in salary and $11.9K in other compensation.

Rankings

In 2021, Purnanand D. Sarma's compensation ranked 5,846th out of 12,415 executives tracked by ExecPay. In other words, Sarma earned more than 52.9% of executives.

ClassificationRankingPercentile
All
5,846
out of 12,415
53rd
Division
Manufacturing
2,475
out of 5,508
55th
Major group
Chemicals And Allied Products
1,074
out of 2,378
55th
Industry group
Drugs
955
out of 2,099
55th
Industry
Pharmaceutical Preparations
685
out of 1,549
56th
Source: SEC filing on April 20, 2023.

Sarma's colleagues

We found two more compensation records of executives who worked with Purnanand D. Sarma at Immunome in 2021.

2021

Dennis Giesing

Immunome

Chief Development Officer

2021

Corleen Roche

Immunome

Chief Financial Officer

News

In-depth

You may also like